To validate if C1QC+ TAMs and SPP1+ TAMs gene signatures can work better than M1 and M2 signatures in other cancers, we also analyzed another single cell data of advanced basal cell carcinoma (BCC) (16). This evidence concerns the gene SPP1 and basal cell carcinoma.